Cargando…

Future of biotherapeutics: Harnessing mRNA to enhance elastin expression

Detalles Bibliográficos
Autores principales:	Crawford, Benjamin C., Elias, Bertha C., Benjamin, John T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682659/ https://www.ncbi.nlm.nih.gov/pubmed/38034029 http://dx.doi.org/10.1016/j.omtn.2023.102069

Ejemplares similares

Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope
por: Aslan, Cynthia, et al.
Publicado: (2021)

De Novo Synthesis of Elastin by Exogenous Delivery of Synthetic Modified mRNA into Skin and Elastin-Deficient Cells
por: Lescan, Mario, et al.
Publicado: (2018)

Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics
por: Ganeshpurkar, Aditya, et al.
Publicado: (2014)

Use of IFN-Based Biotherapeutics to Harness the Host Against Foot-And-Mouth Disease
por: Medina, Gisselle N., et al.
Publicado: (2020)

Manipulation of mRNA translation elongation influences the fragmentation of a biotherapeutic Fc‐fusion protein produced in CHO cells
por: Knight, Tanya J., et al.
Publicado: (2022)

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
por: Anderson, John, et al.
Publicado: (2023)

Cell fate conversion by mRNA
por: Li, Mo, et al.
Publicado: (2011)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Matrin 3 and HIV Rev Regulation of mRNA
por: Dayton, Andrew I
Publicado: (2011)

A Tolerizing mRNA Vaccine against Autoimmunity?
por: Furlan, Roberto
Publicado: (2021)

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies
por: Crombie, Jennifer L., et al.
Publicado: (2021)

Debunking mRNA Vaccine Misconceptions—An Overview for Medical Professionals
por: Hitti, Frederick L., et al.
Publicado: (2021)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Uveitis following mRNA COVID-19 vaccination: Is it real?
por: Murugan, Sivaraman Bala, et al.
Publicado: (2023)

Application of elastin-mimetic recombinant proteins in chemotherapeutics delivery, cellular engineering, and regenerative medicine
por: Jeon, Won Bae
Publicado: (2013)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Harnessing Innate Immunity to Treat Mycobacterium tuberculosis Infections: Heat-Killed Caulobacter crescentus as a Novel Biotherapeutic
por: Gupta, Nancy, et al.
Publicado: (2023)

Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?
por: von Itzstein, Mitchell S., et al.
Publicado: (2020)

Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
por: Kelso, John M.
Publicado: (2021)

mRNA rescues neonatal acidemia while mice report no aftereffects
por: Zimak, Jan, et al.
Publicado: (2019)

NOTCH3 as a modulator of vascular disease: a target in elastin deficiency and arterial pathologies
por: Malka, Kimberly, et al.
Publicado: (2022)

Harnessing smartphone technologies for stroke care, rehabilitation and beyond
por: Zhang, Melvyn W, et al.
Publicado: (2015)

Leading the way: finding genes for neurologic disease in dogs using genome-wide mRNA sequencing
por: Ostrander, Elaine A, et al.
Publicado: (2012)

Coronavirus Disease 2019: Harnessing Healthy Fear via Knowledge, Attitudes, and Behavior
por: O’Neal, Hollis R., et al.
Publicado: (2020)

And the subsidiary lives on: Harnessing complex realities in the contemporary MNE
por: Andrews, Daniel S., et al.
Publicado: (2022)

Commentary on: “Effect of sevoflurane anesthesia on the comprehensive mRNA expression profile of the mouse hippocampus”: Postoperative nausea and vomiting conundrum: RNA-seq to the rescue
por: Ostrowski, Robert P., et al.
Publicado: (2016)

Editorial: Characterization of biotherapeutic products
por: Rathore, Anurag S., et al.
Publicado: (2022)

"Harnessing genomics to improve health in Africa" – an executive course to support genomics policy
por: Smith, Alyna C, et al.
Publicado: (2005)

Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
por: Lahoud, M. H., et al.
Publicado: (2021)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

Overcoming the challenge of long-term storage of mRNA-lipid nanoparticle vaccines
por: Young, Rachel E., et al.
Publicado: (2022)

Harnessing the power of theorising in implementation science
por: Kislov, Roman, et al.
Publicado: (2019)

Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis
por: Bolze, Alexandre, et al.
Publicado: (2022)

Advances in the Development of Biotherapeutics
por: Oliveira, Pedro H., et al.
Publicado: (2015)

Integrated BioTherapeutics
por: Aman, M. Javad
Publicado: (2018)

Harnessing University Strengths in Multisectoral Collaborations for Planetary Health
por: Passarelli, Simone, et al.
Publicado: (2018)

Population-specific design of de-immunized protein biotherapeutics
por: Schubert, Benjamin, et al.
Publicado: (2018)

mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
por: Van Lint, Sandra, et al.
Publicado: (2013)

Low-dose single-shot COVID-19 mRNA vaccines lie ahead
por: Sanders, Niek N.
Publicado: (2021)

A personalized mRNA vaccine has exhibited potential in the treatment of pancreatic cancer
por: Kang, Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bnmoaphh7lu0rqhg219h4uim89